164 related articles for article (PubMed ID: 20017657)
41. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
Fleuranceau-Morel P
Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
[TBL] [Abstract][Full Text] [Related]
42. Alternative business models for drug discovery.
Bunin BA; Ekins S
Drug Discov Today; 2011 Aug; 16(15-16):643-5. PubMed ID: 21745585
[No Abstract] [Full Text] [Related]
43. The business of demographics.
Russell C
Popul Bull; 1984 Jun; 39(3):1-40. PubMed ID: 12313263
[TBL] [Abstract][Full Text] [Related]
44. Optimizing the discovery organization for innovation.
Sams-Dodd F
Drug Discov Today; 2005 Aug; 10(15):1049-56. PubMed ID: 16055021
[TBL] [Abstract][Full Text] [Related]
45. Micro factors bringing the pharmaceutical industry to a seismic shaking a qualitative research.
Dierks RML; Bruyère O; Reginster JY
Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):267-274. PubMed ID: 28679327
[TBL] [Abstract][Full Text] [Related]
46. Industry Update: the latest developments in therapeutic delivery.
Steinbach OC
Ther Deliv; 2013 May; 4(5):531-5. PubMed ID: 23647270
[TBL] [Abstract][Full Text] [Related]
47. The pharmaceutical industry as an informant.
Collier J; Iheanacho I
Lancet; 2002 Nov; 360(9343):1405-9. PubMed ID: 12424005
[TBL] [Abstract][Full Text] [Related]
48. Customer relationship management in the contract pharmaceutical industry: an exploratory study for measuring success.
Kros JF; Nadler S; Molis J
Int J Electron Healthc; 2007; 3(3):353-66. PubMed ID: 18048307
[TBL] [Abstract][Full Text] [Related]
49. Strategic alliances and market risk.
Havenaar M; Hiscocks P
Drug Discov Today; 2012 Aug; 17(15-16):824-7. PubMed ID: 22484547
[TBL] [Abstract][Full Text] [Related]
50. Cloud computing in pharmaceutical R&D: business risks and mitigations.
Geiger K
Curr Opin Drug Discov Devel; 2010 May; 13(3):279-85. PubMed ID: 20443161
[TBL] [Abstract][Full Text] [Related]
51. The development of Bio-pharmaceutical industry in China: problems and solutions.
Yan G
Pak J Pharm Sci; 2014 Jul; 27(4 Suppl):1035-9. PubMed ID: 25016263
[TBL] [Abstract][Full Text] [Related]
52. A report from CPhI Worldwide 2013, Fifth Annual Pre-Connect Conference (October 22-24, 2013 - Frankfurt, Germany).
Kuhrt K; Gilpatrick J
Drugs Today (Barc); 2013 Nov; 49(11):745-50. PubMed ID: 24308020
[TBL] [Abstract][Full Text] [Related]
53. Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry.
Dierks RM; Bruyère O; Reginster JY; Richy FF
Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):571-578. PubMed ID: 27653356
[TBL] [Abstract][Full Text] [Related]
54. Pharmaceutical portfolio management: global disease burden and corporate performance metrics.
Daems R; Maes E; Mehra M; Carroll B; Thomas A
Value Health; 2014 Sep; 17(6):732-8. PubMed ID: 25236997
[TBL] [Abstract][Full Text] [Related]
55. How Do Pharmaceutical Companies Overcome a Corporate Productivity Crisis? Business Diversification into Medical Devices for Growth Potential.
Euh Y; Lee D
Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33503944
[TBL] [Abstract][Full Text] [Related]
56. Challenges and opportunities of drug repositioning.
Novac N
Trends Pharmacol Sci; 2013 May; 34(5):267-72. PubMed ID: 23582281
[TBL] [Abstract][Full Text] [Related]
57. The impact of mergers on pharmaceutical R&D.
LaMattina JL
Nat Rev Drug Discov; 2011 Aug; 10(8):559-60. PubMed ID: 21804580
[TBL] [Abstract][Full Text] [Related]
58. Straight talk with...Shlomo Yanai. Interview by Haim Watzman.
Yanai S
Nat Med; 2010 Mar; 16(3):261. PubMed ID: 20208505
[TBL] [Abstract][Full Text] [Related]
59. Should pharmacometrics be training the next R&D president?
Gobburu JV
Clin Pharmacol Ther; 2014 Jun; 95(6):579-80. PubMed ID: 24842637
[TBL] [Abstract][Full Text] [Related]
60. To outsource in lead discovery: the devil or the deep blue sea?
Mander T; Turner R
J Biomol Screen; 2000 Jun; 5(3):113-8. PubMed ID: 10894753
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
